Latest Stock Split Details
Key information about Quince Therapeutics, Inc.'s most recent stock split
Split Date: 2026-06-30
Split Ratio: 1:20
Price Before Split: $0.91
Price After Split: $0.05
Developer API
Get QNCX split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/QNCX
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Quince Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-06-30 | 1:20 | Yes | $0.91 | $0.05 |
| 2026-04-13 | 1:10 | Yes | $0.14 | $0.01 |
About Quince Therapeutics, Inc.
Company overview and industry information
Quince Therapeutics, Inc. (QNCX) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Quince Therapeutics, Inc. Summary